We may receive a commission on purchases made from links. Before cars came standard with USB slots, they primarily provided electricity through 12V sockets. These components were originally designed ...
Tividenofusp alfa (DNL310; ETV:IDS) launch readiness established ahead of April 5, 2026 Prescription Drug User Fee Act (PDUFA) target action date for Hunter syndrome DNL126 (ETV:SGSH) Phase 1/2 ...
The light is back and there is lots of snow. It’s time to celebrate Denali Winterfest. The kickoff to the weekend celebration takes place from 6-9 p.m. Friday at the McKinley Village Community Center, ...
Sanofi is tight-lipped about the future of its underwhelming pact with Denali Therapeutics after the French pharma scrapped what appeared to be the final RIPK1 inhibitor from the deal. The Paris-based ...
Preparing for FDA approval and commercial launch of tividenofusp alfa, Denali’s TransportVehicle™ (TV)-enabled investigational therapy for Hunter syndrome Expecting multiple clinical data readouts ...
*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title, registration ...
*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title, registration ...
Denali viewed from Talkeetna on March 8, 2025. WASHINGTON — The federal government’s official name for North America’s tallest peak is Mount McKinley. President Trump reinstated the moniker on Day 1 ...
Anchorage Daily News book reviewers Nancy Lord and David James present the 2025 works that they found most memorable and meaningful. Their lists include poetry, works of fiction, adventure stories, a ...
While Denali Therapeutics awaits a delayed FDA decision on its Hunter syndrome drug, the biotech is already banking on the therapy’s commercial success. The agency had originally been due to make an ...
Denali Therapeutics is transitioning from a clinical-stage to a commercial-stage biotech, leveraging its innovative blood-brain barrier TransportVehicle platform. DNLI's financials reflect increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results